SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-043717
Filing Date
2019-08-02
Accepted
2019-08-02 16:02:56
Documents
11
Period of Report
2019-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-16518_28k.htm 8-K 28226
2 EX-10.1 a19-16518_2ex10d1.htm EX-10.1 32510
3 GRAPHIC g165182ksi001.gif GRAPHIC 140697
4 GRAPHIC g165182ksi002.gif GRAPHIC 145644
5 GRAPHIC g165182ksi003.gif GRAPHIC 72306
6 GRAPHIC g165182ksi004.gif GRAPHIC 123902
7 GRAPHIC g165182ksi005.gif GRAPHIC 131043
8 GRAPHIC g165182ksi006.gif GRAPHIC 94123
9 GRAPHIC g165182ksi007.gif GRAPHIC 89790
10 GRAPHIC g165182ksi008.gif GRAPHIC 28632
11 GRAPHIC g165182ksi009.gif GRAPHIC 30631
  Complete submission text file 0001104659-19-043717.txt   1241368
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

IRS No.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50797 | Film No.: 19995956
SIC: 2836 Biological Products, (No Diagnostic Substances)